Kraken Parent Payward Posts $487M Q3 Revenue, EBITDA Down 67%

Payward, the parent company of crypto exchange Kraken, reported $487 million in platform revenue for the third quarter, a 12% decline from a year earlier, according to the company's disclosed results. Adjusted EBITDA fell 67% year over year to $60 million, a figure that translates to roughly $20 million per month of operating profitability across the entire platform.

The quarterly sequence tells a more nuanced story than the annual comparison. Platform revenue rose 12% versus the second quarter, and adjusted EBITDA increased 163% quarter over quarter. Both measures nonetheless remained below their year-earlier levels, which means the sequential recovery has not yet restored the earnings base Payward recorded twelve months ago.

The gap between revenue and profit growth deserves scrutiny. A 12% revenue decline paired with a 67% EBITDA drop implies costs did not fall in proportion to the top line. Payward did not disclose absolute cost figures or segment-level detail, so the source of the margin compression — mix shift, fee compression, or fixed-cost carry — cannot be verified from the published numbers alone.

What drove the top line?

Platform trading volume came in at $353 billion for the quarter, down 30% year over year. That decline in activity is the proximate cause of the revenue contraction: fee-earning volume, not account counts, generates exchange revenue.

Against that volume slump, funded accounts — defined by the company as accounts holding a balance above zero — increased 37% to 7.1 million. For scale, that is roughly one funded account for every fifty residents of the United Kingdom. The divergence matters: customer acquisition is running well ahead of customer activity, and the model only pays off if those accounts eventually trade. Payward offered no data on assets per account or active-trader ratios.

In plain words: Kraken is adding customers faster than it is adding business from them.

Where is the company heading next?

Payward is expanding its tokenized stock business, which would place it in more direct competition with traditional brokerage infrastructure and other crypto-native issuers of equities onchain.

The company also plans several moves that remain contingent or undated:

• Onchain perpetual futures for U.S. customers, offered once the company receives regulatory approval — a condition with no stated timeline
• Entry into prediction markets, a sector currently contested by established operators and pending regulatory boundaries
• Issuance of its own token, with no launch date announced

Each of these plans carries a caveat the disclosure does not resolve. Regulatory approval for perpetual futures in the United States is not a formality; prediction markets face an unsettled rulebook; and a proprietary token invites the same scrutiny that has slowed comparable launches at rival exchanges. None of the three initiatives comes with a deadline, a revenue estimate, or a named regulator.

The takeaway is straightforward: Payward's growth story now rests on product expansion rather than trading volumes, and the expansion itself depends on approvals the company cannot control.

What does this mean for the competitive picture?

The results arrive as crypto exchanges compete on product breadth rather than spot fees alone. Tokenized equities, onchain derivatives, and prediction markets are the three battlegrounds Payward has now named explicitly. Its own token would follow a path trodden by other exchange operators, with mixed results.

The financials suggest a company with a widening customer base but a shrinking profit engine. Sequential improvement is real; annual decline is also real. The 7.1 million funded accounts are an asset only insofar as market activity returns or the new products convert them into revenue-generating users.

Investors and counterparties will watch the fourth quarter for evidence of whether the sequential rebound extends, and whether any of the three announced initiatives — the U.S. perpetual futures launch in particular — clears its regulatory hurdle.